Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Clinical trial NCT00824291 · COMPLETED
Trial details
- NCT number
- NCT00824291
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.